Drug Profile
MTC-MMC
Latest Information Update: 25 Dec 2021
Price :
$50
*
At a glance
- Originator FeRx
- Class Amines; Antiglaucomas; Antineoplastics; Aza compounds; Aziridines; Carbamates; Cytostatic antibiotics; Eye disorder therapies; Heterocyclic compounds with 4 or more rings; Indoles; Mitomycins; Pyrroles; Small molecules
- Mechanism of Action DNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Non-small cell lung cancer
Most Recent Events
- 14 Jan 2004 Preclinical trials in Non-small cell lung cancer in USA (Intra-arterial)